Drug profile · INN
tolterodine tartrate
TOLTERODINE TARTRATE
tolterodine tartrate (TOLTERODINE TARTRATE) is a muscarinic acetylcholine receptor m2 antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — tolterodine tartrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
tolterodine tartrate (TOLTERODINE TARTRATE) is a muscarinic acetylcholine receptor m2 antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M2 antagonist
Primary target: Muscarinic acetylcholine receptor M2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tolterodine tartrate?
tolterodine tartrate (TOLTERODINE TARTRATE) is a muscarinic acetylcholine receptor m2 antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tolterodine tartrate?
TOLTERODINE TARTRATE is a marketed brand name for tolterodine tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tolterodine tartrate?
tolterodine tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.